VivoSim Labs faces Nasdaq minimum bid price deficiency notice, risks delisting if noncompliance persists

PUBT · 2d ago
VivoSim Labs faces Nasdaq minimum bid price deficiency notice, risks delisting if noncompliance persists
  • Nasdaq issued a noncompliance notice on Aug. 17, 2026, citing a sub-$1 bid price for 30 consecutive business days.
  • Shares keep trading on the Nasdaq Capital Market under VIVS, with no immediate impact on listing status.
  • Compliance deadline set for Feb. 16, 2027; stock must close at or above $1 for 10 consecutive business days.
  • Failure to cure could trigger delisting risk, though an additional 180-day extension may be available if eligibility conditions are met.
  • Options include a shareholder-approved reverse stock split, with a proposed ratio range of 1-for-5 to 1-for-20.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VivoSim Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-361085), on August 21, 2026, and is solely responsible for the information contained therein.